文献速递颈动脉与弓上血管

术前mRS 3分患者颈动脉内膜剥脱术的围术期结局:英国国家血管登记分析

Peri-operative Outcomes after Carotid Endarterectomy in Selected Operated Patients with Pre-operative Modified Rankin Scale Score 3: Analysis of the UK National Vascular Registry.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-07-17

校正混杂因素后,mRS 3分与30天卒中、死亡或卒中/死亡均无统计学显著关联,但呼吸系统并发症、术后谵妄、任何内科并发症及住院时间在mRS 3分组更高。

要点

  • 择期手术的mRS 3分患者30天卒中或死亡风险与mRS 0-2分者无显著差异。
  • mRS 3分患者呼吸并发症、术后谵妄等内科并发症及住院时间更高。
  • 结论仅适用于经选择的手术患者,不能推断CEA使所有mRS 3分患者获益。

核心结论

  • 在经选择的手术患者中,术前mRS 3分与mRS 0-2分相比,注册记录的30天卒中或30天卒中/死亡无统计学显著增加,但内科并发症和资源使用更高。

研究设计与样本

  • 回顾性观察性队列研究,分析英国国家血管登记前瞻性收集的数据。
  • 主要结局为30天卒中、注册记录的30天死亡及30天卒中或死亡,采用多因素logistic回归校正年龄、性别、吸烟、糖尿病、高血压、缺血性心脏病、充血性心力衰竭、心房颤动、慢性肾功能衰竭、癌症和慢性肺病。

主要发现

  • 校正后mRS 3分与30天卒中(OR 1.32,95%CI 0.83-2.08;p = .24)、观察到的30天死亡(OR 0.36,95%CI 0.05-2.72;p = .32)、30天卒中或死亡(OR 1.26,95%CI 0.80-1.97;p = .31)均无显著关联。
  • mRS 3分组呼吸系统并发症、术后谵妄、任何内科并发症及住院时间更高;敏感性分析结果基本不变,未发现明确的性别交互作用。

临床怎么用

  • 对于经选择的mRS 3分卒中患者,CEA的围术期卒中/死亡风险与mRS 0-2分者相近,但需关注更高的内科并发症和资源使用。
  • 该数据不能外推至所有mRS 3分患者,因缺乏单纯药物治疗对照组且死亡随访不完整。

局限性

  • 无药物治疗对照组,不能评估CEA相对于药物治疗的获益。
  • 为回顾性观察性研究,结论仅适用于经选择的手术患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Randomised controlled trials supporting carotid endarterectomy (CEA) for symptomatic carotid stenosis provide little direct evidence for patients with disabling stroke. This study evaluated whether selected operated patients with a pre-operative modified Rankin scale (mRS) score of 3 had a higher peri-operative risk than operated patients with mRS scores of 0 - 2. METHODS: This was a retrospective, observational cohort study of prospectively collected national registry data. The UK National Vascular Registry was analysed for adults undergoing CEA for stroke between 2021 and 2023 with 50 - 99% ipsilateral carotid stenosis. Primary outcomes were 30 day stroke, registry recorded 30 day death, and 30 day stroke or death. Multivariable logistic regression adjusted for age, sex, smoking, diabetes, hypertension, ischaemic heart disease, congestive cardiac failure, atrial fibrillation, chronic renal failure, cancer, and chronic lung disease. Pre-specified sensitivity analyses compared mRS 3 separately with mRS 0 - 1 and mRS 2, added operative and medical therapy covariables, excluded thrombolysis, assessed death follow up completion, and provided sex disaggregated outcomes. RESULTS: Of 6 632 patients, 946 (14.3%) had mRS 3. Follow up stroke data were complete in 6 578 of 6 632 (99.2%), whereas the dedicated 30 day death field was complete in 4 301 of 6 632 (64.9%). Thirty day stroke occurred in 23 of 946 patients (2.4%) with mRS 3 and 106 of 5 686 (1.9%) with mRS 0 - 2 (p = .24); observed 30 day death in one of 946 (0.1%) and 18 of 5 686 (0.3%) (p = .51); and 30 day stroke or death in 24 of 946 (2.5%) and 117 of 5 686 (2.1%) (p = .34). After adjustment, mRS 3 was not associated with 30 day stroke (odds ratio [OR] 1.32, 95% confidence interval [CI] 0.83 - 2.08; p = .24), observed 30 day death (OR 0.36, 95% CI 0.05 - 2.72; p = .32), or 30 day stroke or death (OR 1.26, 95% CI 0.80 - 1.97; p = .31). Respiratory complications, post-operative confusion, any medical complication, and hospital length of stay were higher in the mRS 3 group. Sensitivity analyses were materially unchanged, and no convincing interaction by sex was identified. CONCLUSION: Among selected patients who underwent surgery, pre-operative mRS 3 was not associated with a statistically significant increase in registry recorded 30 day stroke or 30 day stroke or death compared with operated patients with mRS 0 - 2, although medical morbidity and resource use were higher. Because there was no medically treated comparator and mortality follow up was incomplete, these findings inform peri-operative risk in selected surgical candidates only and should not be interpreted as evidence that CEA benefits all patients with mRS 3.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Baker DM, Cruddas L, Benaragama S, et al. Peri-operative Outcomes after Carotid Endarterectomy in Selected Operated Patients with Pre-operative Modified Rankin Scale Score 3: Analysis of the UK National Vascular Registry. Eur J Vasc Endovasc Surg. 2026. PMID: 42462865. doi:10.1016/j.ejvs.2026.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。